122433-41-4 Usage
Description
METHYL 5-BROMO-2-METHOXYNICOTINATE 98%METHYL 5-BROMO-2-METHOXY-3-PYRIDINECARBOXYLATE, also known as Methyl 5-Bromo-2-Methoxy-3-Pyridinecarboxylate, is an analytical standard representing a chemical substance used in scientific research and industrial manufacturing. It is composed of chemical constituents such as bromine, methyl, and nicotinate, and is characterized by a stable pyridine ring in its structure. METHYL 5-BROMO-2-METHOXYNICOTINATE 98%METHYL 5-BROMO-2-METHOXY-3-PYRIDINECARBOXYLATE typically comes in a high purity of 98%, indicating its relatively high concentration.
Uses
Used in Scientific Research:
METHYL 5-BROMO-2-METHOXYNICOTINATE 98%METHYL 5-BROMO-2-METHOXY-3-PYRIDINECARBOXYLATE is used as a chemical standard for calibration of laboratory equipment and testing procedures. Its high purity and stable structure make it a reliable reference material in various analytical processes.
Used in Industrial Manufacturing:
METHYL 5-BROMO-2-METHOXYNICOTINATE 98%METHYL 5-BROMO-2-METHOXY-3-PYRIDINECARBOXYLATE is used as a raw material or intermediate in the synthesis of various chemical products. Its unique chemical properties, such as the presence of bromine and a pyridine ring, contribute to the development of new compounds and materials in the industry.
Check Digit Verification of cas no
The CAS Registry Mumber 122433-41-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,2,4,3 and 3 respectively; the second part has 2 digits, 4 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 122433-41:
(8*1)+(7*2)+(6*2)+(5*4)+(4*3)+(3*3)+(2*4)+(1*1)=84
84 % 10 = 4
So 122433-41-4 is a valid CAS Registry Number.
122433-41-4Relevant articles and documents
Nitrogen-containing heterocyclic compound as well as preparation method, pharmaceutical composition and application thereof
-
, (2020/05/02)
The invention provides a nitrogen-containing heterocyclic compound as well as a preparation method, a pharmaceutical composition and application thereof, and particularly provides a compound as shownin a formula I which is described in the specification,
NOVEL COMPOUNDS FOR THE TREATMENT OF HEPATITIS C
-
Page/Page column 33, (2016/09/26)
The disclosure provides compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds have activity against hepatitis C virus (HCV) and may be useful in treating those infected with HCV.
HYDROXAMIC ACID DERIVATIVES AS GRAM-NEGATIVE ANTIBACTERIAL AGENTS
-
Page/Page column 88-89, (2010/09/18)
The invention relates to chemical compounds of formula (IB): or a salt thereof. In some embodiments, the invention relates to inhibitors of UDP-3-0 — (R-S-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC). In still further embodiments, the invention relates to pharmaceutical compositions comprising compounds disclosed herein and their use in the prevention and/or treatment of Gram- negative bacterial infections.
